Bruce F Bell

Array ( [id] => 11480388 [patent_doc_number] => 09586916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Integrin antagonist conjugates for targeted delivery to cells expressing alpha-V-beta-3' [patent_app_type] => utility [patent_app_number] => 14/374680 [patent_app_country] => US [patent_app_date] => 2013-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16696 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9813290 [patent_doc_number] => 20150025236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'PROCESS FOR THE PREPARATION OF STABLE CRYSTALLINE FORM-I OF LINEZOLID, SUBSTANTIALLY FREE OF RESIDUAL SOLVENT' [patent_app_type] => utility [patent_app_number] => 14/374213 [patent_app_country] => US [patent_app_date] => 2013-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15472 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928711 [patent_doc_number] => 20130184471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'Process for the preparation of bendamustine hydrochloride and related compounds' [patent_app_type] => utility [patent_app_number] => 13/742434 [patent_app_country] => US [patent_app_date] => 2013-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8833 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13742434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968246 [patent_doc_number] => 20140371278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'BENZOHETEROCYCLIC COMPOUNDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/372731 [patent_app_country] => US [patent_app_date] => 2013-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 70385 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14372731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10614842 [patent_doc_number] => 09334276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor' [patent_app_type] => utility [patent_app_number] => 14/370124 [patent_app_country] => US [patent_app_date] => 2013-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7365 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831610 [patent_doc_number] => 08859780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Benzimidazole derivatives as selective blockers of persistent sodium current' [patent_app_type] => utility [patent_app_number] => 13/727860 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26342 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13727860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882818 [patent_doc_number] => 08969583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => '3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/728502 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24203 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13728502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990382 [patent_doc_number] => 20130217663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'NOVEL S1P RECEPTOR MODULATING AGENT' [patent_app_type] => utility [patent_app_number] => 13/723900 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25262 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13723900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10961440 [patent_doc_number] => 20140364466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'Isothiazoline compounds for combating invertebrate pests' [patent_app_type] => utility [patent_app_number] => 14/366161 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90693 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14366161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534803 [patent_doc_number] => 09260423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Process for the preparation of a thioprecursor for statins' [patent_app_type] => utility [patent_app_number] => 14/363986 [patent_app_country] => US [patent_app_date] => 2012-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4151 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10926837 [patent_doc_number] => 20140329858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'Cyclic Urea Derivatives As Androgen Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 14/361728 [patent_app_country] => US [patent_app_date] => 2012-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37498 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9692103 [patent_doc_number] => 08822698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the Met family' [patent_app_type] => utility [patent_app_number] => 13/686985 [patent_app_country] => US [patent_app_date] => 2012-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16409 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13686985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560669 [patent_doc_number] => 09284328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Organic compound' [patent_app_type] => utility [patent_app_number] => 14/368471 [patent_app_country] => US [patent_app_date] => 2012-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7141 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977440 [patent_doc_number] => 20130210870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'DESFERRITHIOCIN POLYETHER ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/683301 [patent_app_country] => US [patent_app_date] => 2012-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21592 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13683301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699511 [patent_doc_number] => 20140249196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'N-BENZYLBENZIMIDAZOLE MODULATORS OF PPARG' [patent_app_type] => utility [patent_app_number] => 13/811969 [patent_app_country] => US [patent_app_date] => 2012-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23936 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932851 [patent_doc_number] => 08492554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Chemical compounds' [patent_app_type] => utility [patent_app_number] => 13/677358 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25581 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13677358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854260 [patent_doc_number] => 20130143935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/674710 [patent_app_country] => US [patent_app_date] => 2012-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 29079 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13674710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814148 [patent_doc_number] => 20130115193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Hepatitis C Virus Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/672266 [patent_app_country] => US [patent_app_date] => 2012-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 210383 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11463793 [patent_doc_number] => 09580409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'Modulators of opioid receptors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/352294 [patent_app_country] => US [patent_app_date] => 2012-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27549 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548423 [patent_doc_number] => 09273034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Meglumine salt formulations of 1-(5,6-dichloro-1H-benzo[D]imidazol-2-yl)-1H-pyrazole-4-carboxylic acid' [patent_app_type] => utility [patent_app_number] => 14/353241 [patent_app_country] => US [patent_app_date] => 2012-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11119 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353241 [rel_patent_id] =>[rel_patent_doc_number] =>)